“In my opinion, Dr. J missed the main reason for strained relations between the FDA and Cytodyn. (Surprising to me!) That reason is - Pourhassan will not let the FDA get its hooks into Leronlimab and all the indications it can treat!”

Zero logic behind this theory. The FDA doesn’t like CYDY because of NP and that’s due to missteps such as filing a BTD with 2 patients and HIV BLA, which NP knowingly submitted incomplete.